Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wade Sexton

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
European Urology Focus|June 1, 2023
Route of Administration for UGN-101 and Impact on Oncological and Safety OutcomesJennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
Urologic Oncology|May 28, 2023
The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinomaHristos Z Kaimakliotis, Isamu Tachibana, Solomon Woldu, et al.
Urologic Oncology|November 24, 2022
Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomesSolomon L Woldu, Craig Labbate, Katie S Murray, et al.
Urologic Oncology|January 21, 2025
Durability of response of UGN-101: Longitudinal follow up of multicenter studySolomon L Woldu, Daniel Igel, Brett Johnson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 2, 2024
Pathogenic Roles for RNASET2 in Clear Cell Renal Cell CarcinomaTaylor Peak, Yijun Tian, Aman Patel, et al.
The Journal of Urology|November 13, 2025
Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients Undergoing Bladder-preserving Trimodality TherapyDekuang Zhao, Vaseem M Khatri, Justyn Y Nakashima, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
European Urology Focus|June 1, 2023
Route of Administration for UGN-101 and Impact on Oncological and Safety OutcomesJennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
Urologic Oncology|May 28, 2023
The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinomaHristos Z Kaimakliotis, Isamu Tachibana, Solomon Woldu, et al.
Urologic Oncology|November 24, 2022
Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomesSolomon L Woldu, Craig Labbate, Katie S Murray, et al.
Urologic Oncology|January 21, 2025
Durability of response of UGN-101: Longitudinal follow up of multicenter studySolomon L Woldu, Daniel Igel, Brett Johnson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 2, 2024
Pathogenic Roles for RNASET2 in Clear Cell Renal Cell CarcinomaTaylor Peak, Yijun Tian, Aman Patel, et al.
The Journal of Urology|November 13, 2025
Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients Undergoing Bladder-preserving Trimodality TherapyDekuang Zhao, Vaseem M Khatri, Justyn Y Nakashima, et al.
Pageof 3